[Frontiers in vitamin D; Basic research and clinical application. Effect of eldecalcitol on bone structure]

Area of Science:

• Endocrinology
• Orthopedics
• Bone Metabolism

Background:

• Osteoporosis is a major health concern, increasing fracture risk.
• Vitamin D compounds are crucial for bone health management.
• Alfacalcidol is a traditional active vitamin D treatment.

Purpose of the Study:

• To compare the efficacy of eldecalcitol and alfacalcidol in preventing fractures.
• To investigate the effects of eldecalcitol on bone microstructure and biomechanical properties.

Main Methods:

• Animal studies assessing bone metabolism and microstructure (BV/TV, Tb.N, Tb.Th, Tb.Sp).
• Three-year longitudinal observation using multi-detector row CT to evaluate hip geometry and biomechanical parameters.
• Comparison of eldecalcitol and alfacalcidol effects on cortical bone (cross-sectional area, bone mass, perimeter, thickness) and endocortical resorption.

Main Results:

• Eldecalcitol demonstrated superiority over alfacalcidol in preventing vertebral and major non-vertebral fractures.
• Animal studies showed greater efficacy of eldecalcitol in improving trabecular bone microstructure.
• Longitudinal CT data revealed eldecalcitol enhances hip biomechanical properties by increasing cortical bone and reducing resorption.

Conclusions:

• Eldecalcitol offers superior fracture prevention in osteoporotic subjects compared to alfacalcidol.
• Eldecalcitol positively impacts both trabecular and cortical bone, improving bone strength and microarchitecture.
• The enhanced effect on cortical bone resorption mitigation may contribute to eldecalcitol's superior anti-fracture efficacy.